The logo of the Catalent plant is seen in Anagni, Italy, March 24, 2021. REUTERS/Yara NardiCTLT +2.72% Add to/Remove from Watchlist NVO +2.65% Add to/Remove from Watchlist MRNA -0.32% Add to/Remove from Watchlist(Reuters) -Activist investor Elliott Investment has built a significant stake in Catalent (NYSE: ) and is pushing for a shake-up on the contract drug manufacturer's board, the Wall Street Journal reported on Wednesday. The exact size of Elliott's stake in Catalent could not be learned, WSJ added. Catalent manufactures drugs, vaccines and gene therapies at 55 different sites for major pharmaceutical companies, including Moderna (NASDAQ: ) Inc's COVID-19 vaccine. Elliott and Catalent did not immediately respond to Reuters' requests for comment.

Source: Wall Street Journal July 20, 2023 05:31 UTC